RxDoctor Payments Data

Shari Reitzen-Bastidas, MD

Facial Plastic Surgery · New York, NYNPI 1225173370

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.3% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Acclarent, Inc at 31.7% of the total. Reporting peaked in 2019 at $358 and has fallen 94.0% since, to $21 in 2024. That places this record below the midpoint for facial plastic surgery clinicians in NY, where the typical reported total is $1,459.

$829in general payments, 2019–2025

Across 21 payments — averaging $39.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$263
  • Stryker$119
  • Intersect ENT, Inc.$115
  • Musculoskeletal Transplant Foundation Inc.$85
  • Welch Allyn$64
  • Optinose US, Inc.$62
  • plus $121 from 6 others

What the payments were for

  • Food & beverage$76592%
  • Other$648%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$829 in reported general payments places this provider in the 35th percentile of 48 facial plastic surgery providers in New York.

See all facial plastic surgery providers in New York

Medicare billing

Part B allowed, 2024
$10,533
Medicare patients
29
Services billed
83

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide20$534
Fluticasone Propionate25$432

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →